NIH-funded research NIH-funded research

Testing inhaled tobramycin for very preterm infants with lung disease

Official title: Phase 1 trial of inhaled tobramycin in very preterm infants with bronchopulmonary dysplasia

Funded at Children's Hosp of Philadelphia · NIH-10688294 · Data updated 2026-11-12

This study is looking at how inhaled tobramycin, an antibiotic, can help very preterm babies with bronchopulmonary dysplasia (BPD) by delivering the medicine straight to their lungs to fight harmful bacteria and improve their breathing.

More Preterm research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionChildren's Hosp of Philadelphia
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startAugust 20, 2021
Project endJuly 31, 2025
Funding year2023
Award (this year)$308,000
NIH project number5R34HL155690-03
Project IDNIH-10688294 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are very preterm infants diagnosed with bronchopulmonary dysplasia.

Less likely to help

Patients who are not very preterm infants or do not have bronchopulmonary dysplasia may not benefit from this research.

What this research studies

This research investigates the use of inhaled tobramycin, an antibiotic, to treat very preterm infants suffering from bronchopulmonary dysplasia (BPD), a serious lung condition. The study aims to deliver the medication directly to the lungs, where it can effectively target harmful bacteria that worsen respiratory health. By focusing on this method, the research seeks to improve outcomes for infants who currently have limited treatment options. The trial will assess the safety and effectiveness of this approach in a vulnerable population.

Why it matters

Potential benefit: If successful, this research could lead to improved respiratory health and quality of life for very preterm infants with bronchopulmonary dysplasia.

How similar studies have gone: Previous research has shown promising results with inhaled antibiotics in similar conditions, suggesting potential for success in this trial.

Where this research is happening

  • Children's Hosp of Philadelphia
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Downes, Kevin James — Children's Hosp of Philadelphia
  • Study coordinator: Downes, Kevin James

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.